Cost per QALY gained

Graph Information

This graph shows the estimated incremental cost effectiveness ratio (i.e. cost per quality-adjusted life year, QALY gained), associated with targeted testing and treatment (TTT) for latent tuberculosis infection (LTBI) across five key populations in four U.S. states. More cost-effective interventions appear to the left (e.g., TTT among persons living with HIV is more cost-effective than among persons with diabetes).

TTT for persons who are incarcerated was more costly and less effective compared to TTT at current levels^† in New York. As a consequence, there is no estimate of cost effectiveness for TTT among persons experiencing incarceration from New York represented on this graph.

^† Cohen DJ, Reynolds MR. Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol 2008;52(25):2119-26